PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise) is Buildings and Property in United States that focus on drug development platform business. They cover business area such as herpe drug development platform and manufacturing expertise, Pittsburgh, Pennsylvania, oncolytic and other herpe simplex virus, (HSV, base asset, precise modification, customization, viral trait, replication capacity, tissue specificity, expression, payload, immunomodulator.
-
Drug Development Platform
-
2403 Sidney Street
Suite 255
Pittsburgh, PA 15203
United States
Private
herpe drug development platform and manufacturing expertisePittsburghPennsylvaniaoncolytic and other herpe simplex virus(HSVbase assetprecise modificationcustomizationviral traitreplication capacitytissue specificityexpressionpayloadimmunomodulator
* We use standard office opening hours in near PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PeriphaGen (Herpes Drug Development Platform And Manufacturing Expertise) is Buildings and Property business from United States that founded in - ( years old in ), PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise) business is focusing on Drug Development Platform.
PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise) headquarter office and corporate office address is located in 2403 Sidney Street Suite 255 Pittsburgh, PA 15203 United States.
PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise) was founded in United States.
In , PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise) is currently focus on drug development platform sector.
Above is snippet of Google Trends for "drug development platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
